Catalyst Wire Dossier Catalyst Wire Dossier

Insulin aspart (NovoLog)

insulin aspart · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Insulin aspart (NovoLog), covering 2012-07-25 to 2017-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes [Phase 4]

See pricing